Gastrointestinal side effect profile due to the use of alendronate in the treatment of osteoporosis


Creative Commons License

Aki S., Eskiyurt N., Akarirmak U., Tuzun F., Eryavuz M., Alper S., et al.

YONSEI MEDICAL JOURNAL, cilt.44, ss.961-967, 2003 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 44 Konu: 6
  • Basım Tarihi: 2003
  • Doi Numarası: 10.3349/ymj.2003.44.6.961
  • Dergi Adı: YONSEI MEDICAL JOURNAL
  • Sayfa Sayısı: ss.961-967

Özet

The aim of our study was to evaluate the upper gastrointestinal (GI) tract side effect profile in 759 female patients that had taken alendronate (10 mg/day), for at least 6 months, for the treatment of osteoporosis, in relation to the safety of alendronate and the compliance of patients to its absorption rules.